Print page      E-mail page

Investor Relations The investor pages that follow are your resource for financial information about Poniard Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information. Recent Releases Nov 6, 2008 Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin Oct 30, 2008 Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update more » Events Dec 2, 2008 Piper Jaffray 20th Annual Health Care Conference Nov 19, 2008 Lazard Capital Markets 5th Annual Healthcare Conference more »

Stock Information PARD - (NASD) $2.52   - 0.37 Nov 21, 2008 4:00 PM ET  Shareholder Tools Investor Briefcase Investor Kit News & Event Alerts Download Library Glossary Investor FAQs News Feeds Investor site Section only Quotes delayed at least 20 minutes. Information provided by eSignal.